Liliana Mendonça

University of Coimbra — Portugal

Neuroscience · Life Sciences

17h-index1.0kcitations46works12.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Neurodegenerative Diseases(16), RNA Interference and Gene Delivery(14), Mitochondrial Function and Pathology(8), Pluripotent Stem Cells Research(8), Virus-based gene therapy research(8)

Publications46 total

Advanced therapy medicinal products development - from guidelines to medicines in the market
Biotechnology Advances·2025· 8 citedOpen Access
Autophagy- and oxidative stress-related protein deregulation mediated by extracellular vesicles of human MJD/SCA3 iPSC-derived neuroepithelial stem cells and differentiated neural cultures
Cell Death and Disease·2025· 3 citedOpen Access
Editorial on Special Issue “State-of-Art in mRNA Therapeutics and Gene Delivery”
Pharmaceutics·2024Open Access
Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands
Journal of Nanobiotechnology·2024· 61 citedOpen Access
Graft-derived neurons and bystander effects are maintained for six months after human iPSC-derived NESC transplantation in mice’s cerebella
Scientific Reports·2024· 1 citedOpen Access
Strategies to Upgrade the Stem Cell Application for Brain Transplantation
Stem cell biology and regenerative medicine·2024
Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3
Molecular Therapy·2023· 34 citedOpen Access
Editorial: Global excellence in gene and cell therapy: Europe
Frontiers in Medicine·2023Open Access
Editorial: Advanced (gene and cell) therapies for central nervous system applications
Frontiers in Molecular Neuroscience·2023Open Access
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits
Brain·2022· 27 citedOpen Access
The stress granule protein G3BP1 reduces the levels of polyglutamine proteins and alleviates spinocerebellar ataxia associated deficits
2022Open Access
Metabolic syndrome parameters and multiple sclerosis disease outcomes: A Portuguese cross-sectional study
Multiple Sclerosis and Related Disorders·2022· 7 cited
Establishment and characterization of human pluripotent stem cells-derived brain organoids to model cerebellar diseases
Scientific Reports·2022· 17 citedOpen Access
Extracellular Vesicles Physiological Role and the Particular Case of Disease-Spreading Mechanisms in Polyglutamine Diseases
International Journal of Molecular Sciences·2021· 6 citedOpen Access
The stress granule protein G3BP1 reduces the levels of different polyglutamine proteins and alleviates spinocerebellar ataxia associated deficits
2021Open Access
Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach
International Journal of Molecular Sciences·2020· 6 citedOpen Access
CYP46A1- gene therapy improves Machado-Joseph disease in mouse models
Sapientia (Algarve University)·2020Open Access
Gene Therapy Applications
2020· 1 cited
Viral Vectors for Gene Therapy
2020· 4 cited
Stem Cells and Tissue Regeneration
2020· 1 cited
page 1 of 3Next →

Frequent Co-authors

Clévio Nóbrega(28), Luís Pereira de Almeida(24), Carlos A. Matos(17), Maria C. Pedroso de Lima(8), Ricardo Moreira(7), João Nuno Moreira(6), Adriana Marcelo(6), Sandra O. Tomé(6), Daniel Henriques(6), Sérgio Simões(5), Pedro M. Costa(4), Célia Gomes(4), Hirokazu Hirai(4), Rebekah Koppenol(4), André Conceição(4), Mariana Conceição(3), Johannes Boltze(3), N. Manjunath(2), Brian K. Kaspar(2), Antonin Lamazière(2)